Correlation Between Dupont De and Vytrus Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Vytrus Biotech SA, you can compare the effects of market volatilities on Dupont De and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Vytrus Biotech.

Diversification Opportunities for Dupont De and Vytrus Biotech

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dupont and Vytrus is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Dupont De i.e., Dupont De and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Dupont De and Vytrus Biotech

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.36 times more return on investment than Vytrus Biotech. However, Dupont De Nemours is 2.78 times less risky than Vytrus Biotech. It trades about 0.12 of its potential returns per unit of risk. Vytrus Biotech SA is currently generating about -0.03 per unit of risk. If you would invest  6,090  in Dupont De Nemours on August 28, 2024 and sell it today you would earn a total of  2,353  from holding Dupont De Nemours or generate 38.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.58%
ValuesDaily Returns

Dupont De Nemours  vs.  Vytrus Biotech SA

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Dupont De and Vytrus Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Vytrus Biotech

The main advantage of trading using opposite Dupont De and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.
The idea behind Dupont De Nemours and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data